Alignment Healthcare used its slot at the 44th annual J.P. Morgan Healthcare Conference to deliver a confident update on its growth trajectory and long-term strategy. CEO John Kao and CFO Thomas Freeman outlined how the company has strengthened its operating model in 2025 achieving meaningful improvements in Star Ratings, member retention, and medical cost trends while continuing to expand its membership base in a highly competitive Medicare Advantage landscape.

Central to Alignment’s strategy is its differentiated care management approach, which combines proprietary technology, in-home visits, virtual care, and 24/7 clinical support to proactively manage high-risk seniors. The company’s “ALIGN” model emphasises early identification of rising-risk members, personalised care plans, and close coordination with primary care physicians and specialists. This high-touch, tech-enabled model has contributed to lower hospitalisation rates, fewer emergency department visits, and better management of chronic conditions compared to industry benchmarks.

At JPM26, Alignment highlighted several key achievements and forward-looking goals:

Sustained membership growth in core California markets and expansion into new geographies, with expectations of continued double-digit increases through 2027–2028

Meaningful improvement in Medicare Star Ratings, driven by better clinical quality measures and member experience scores

Ongoing reduction in medical cost trends through enhanced care management, risk adjustment accuracy, and network optimisation

Investment in technology including AI-supported risk stratification, predictive analytics, and virtual care tools to further improve efficiency and outcomes

Strong liquidity position and disciplined capital allocation to support organic growth and potential tuck-in acquisitions

Kao reiterated the company’s long-term vision: to become the leading Medicare Advantage platform for seniors who want high-quality, coordinated care delivered in a way that respects their independence and dignity. He emphasised that Alignment’s focus on value-based care rather than volume-driven fee-for-service models positions the company well as CMS continues to push quality-linked reimbursement and risk adjustment refinements.

The presentation was well-received by investors, with several analysts noting Alignment’s consistent execution, improving margins, and clear differentiation in a crowded Medicare Advantage market. While acknowledging ongoing industry headwinds (regulatory changes, reimbursement pressures, and competitive bidding), management expressed confidence in the company’s ability to grow profitably while delivering superior care to members.